New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .
NBC reports that patients taking
Novo Nordisk's obesity treatment maintain
an average of 10% weight loss over four years.
The..
Credit: Wibbitz Top Stories Duration: 01:31Published
Latest Weight-Loss Drug , Faces Shortages .
The United States Food and Drug Administration
(FDA) says that high demand has left the latest
weight-loss drug, Zepbound, in short supply.
'Newsweek'..
Credit: Wibbitz Top Stories Duration: 01:30Published
Saturday, 4 May 2024 ()
![New Analysis Suggests Long-Term Effectiveness for Wegovy Users [Video]](https://video.newsserve.net/300/v/20240514/1375493648-New-Analysis-Suggests-Long-Term-Effectiveness-for-Wegovy.jpg)
![Latest Weight-Loss Drug Faces Shortages [Video]](https://video.newsserve.net/300/v/20240418/1373021964-Latest-Weight-Loss-Drug-Faces-Shortages.jpg)
